Skip to main content
Premium Trial:

Request an Annual Quote

CareDx Inks Supply Agreement with Illumina

NEW YORK (GenomeWeb) – Transplant molecular diagnostics company CareDx today announced a supply agreement with Illumina for next-generation sequencing technologies.

Under the terms of the multiyear deal, CareDx's reference and R&D laboratories will have access to Illumina's NGS, microarray equipment, and consumables. Financial and other terms were not disclosed.

CareDx's flagship service is AlloMap Molecular Expression Testing for potential heart transplant rejection. In a statement, the company's President and CEO Peter Maag said that as CareDx expands its product pipeline from the gene expression-based AlloMap to cell-free DNA-based tests, "we believe the technology solutions from Illumina will effectively support our development and commercialization efforts."

Formerly called XDx, CareDx also recently announced the acquisition of transplant firm ImmuMetrix.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Gene Linked to Alkaline Sensitivity in Plants Identified

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.